3 nights, 5 appointments
Help Test a New Treatment for Kidney Disease
This clinical study is evaluating a new treatment for PKD1 mutation-associated autosomal dominant polycystic kidney disease (ADPKD), a condition that results in kidney failure. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.